Ultrasound-Guided Continuous Serratus Anterior Plane Block vs Dexmedetomidine Infusion in Patients With Rib Fractures.
Pain
About this trial
This is an interventional treatment trial for Pain focused on measuring Serratus anterior, Dexmedetomidine, Rib, Fractures
Eligibility Criteria
Inclusion Criteria: Age ≥18 years Rib fracture score of more than 7 Patient with isolated multiple rib fractures, ●American Society of Anesthesiologists classification of physical status < IV Body mass index (BMI) ≤ 35. Exclusion Criteria: Refusal of the patient Trauma survey include multiple injuries including head injuries, visceral and long bone fractures Intubated patients Known hypersensitivity to any study medication, ●Chronic opioid use or chronic pain patient, ●Hemodynamic instability Haemothorax or pneumothorax.
Sites / Locations
- Beni-Suef University hospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
US-guided SAP block group
Dexmedetomidine group
Patients will receive US-guided SAP block with a bolus of 2 mg/kg levobupivacaine made up to a volume of 40 ml followed by an infusion of 0.125% levobupivacaine will be commenced at rate of 8 ml/hr for 48 hr.
Patients will receive initial loading dose of dexmedetomidine of 1 µg/kg over 30 min followed by a continuous infusion at a rate of 0.5 µg/kg/hr for 48 hr.